Table 1. Average IC50 values of STX140, STX243, STX66, paclitaxel, ENMD1198, vinorelbine and colchicine in (a) MCF-7 and (b) MDA-MB-231 cells.
MCF-7 cells Avg IC50 values (μM) | Mock | pALTER-TUBB3 | siRNA-tubb3 |
---|---|---|---|
(a) | |||
STX140 | 0.98 | 1.06 | 0.92 |
STX243 | 0.69 | 0.81 | 0.73 |
2-MeOE2 | 0.99 | 0.97 | 0.98 |
Paclitaxel | 7.2 × 10−6 | 1 × 10−4** | 4.8 × 10−6* |
Vinorelbine | 0.06 | 1** | 0.01* |
ENMD1198 | 0.57 | 0.61 | 0.45 |
Colchicine | 0.024 | 0.029 | 0.029 |
MDA-MB-231 cells Avg IC50 values (μM) | Mock | pALTER-TUBB3 | siRNA-tubb3 |
(b) | |||
STX140 | 0.05 | 0.08 | 0.07 |
STX243 | 0.08 | 0.10 | 0.09 |
2-MeOE2 | 0.99 | 0.98 | 0.99 |
Paclitaxel | 2 × 10−6 | 4 × 10−6*** | <1 × 10−7** |
Vinorelbine | 0.12 | 0.25** | 0.12 |
ENMD1198 | 0.08 | 0.09 | 0.09 |
Colchicine | 0.037 | 0.042 | 0.029 |
Cells were transfected with pALTER-TUBB3 or siRNA-tubb3. They were then exposed to STX140, STX243, paclitaxel, STX66, ENMD1198, vinorelbine or colchicine for 4 days and the IC50 values were obtained from a graph of percent proliferation vs inhibitor concentration and calculated using Prism (Graphpad Software). ***P<0.001, **P<0.01 and *P<0.05.